Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 716.00
Bid: 692.00
Ask: 728.00
Change: 6.00 (0.85%)
Spread: 36.00 (5.202%)
Open: 700.00
High: 720.00
Low: 692.00
Prev. Close: 710.00
PRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition and Licensing agreement

26 Sep 2013 07:00

RNS Number : 9175O
Porvair PLC
26 September 2013
 



FOR IMMEDIATE RELEASE 26 September 2013

 

 

 

Licensing agreement with Thermo Fisher Scientific

 and

Acquisition of Thomas Cain Inc

Porvair plc ("Porvair"), the specialist filtration and environmental technology group today, today announces two agreements to advance its interests in the life science and environmental laboratory markets.

A technology licensing agreement has been struck with Thermo Electron Manufacturing Ltd, a division of Thermo Fisher Scientific ("Thermo"), a global leader in scientific and laboratory supplies. Under this agreement, Porvair and Thermo will commercialise an exclusive range of life science sample preparation filters. Porvair has licensed its filter technology and will manufacture the products. Thermo will undertake sales and marketing of the filters worldwide.

 

In an unrelated agreement, Porvair has acquired the business and assets of Thomas Cain Inc, a manufacturer of environmental laboratory equipment and consumables. This small acquisition will add a complementary range of block digestion instruments and consumables to Seal's water quality analysis products. The business will be integrated into Seal Analytical's operation in Wisconsin, USA.

 

Ben Stocks, Group Chief Executive, commented:

"As part of Porvair's focus on new product development, we have been working for several years with Thermo to develop a range of laboratory sample preparation products, which we are excited to see move into the commercial phase. Porvair has received a technology transfer fee and, in addition, will generate manufacturing margins and royalties on future revenues.

 

"I am pleased to welcome the staff of Thomas Cain into the Porvair Group. Their high quality product range is highly complementary to that offered by Seal Analytical and will fit well with sales and marketing programmes already underway."

 

 

For further information, please contact:

 

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

Chris Tyler, Group Finance Director

Buchanan

0207 466 5000

Charles Ryland / Helen Greenwood / Clare Akhurst

 

Notes to Editors

Porvair is a group of specialist filtration and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. Its principal markets are aviation, energy and industrial process, environmental laboratories and non-ferrous metals.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBUGDCGUDBGXU
Date   Source Headline
21st Apr 20201:59 pmRNSAGM resolutions and Board changes
8th Apr 20204:03 pmRNSBlock listing six monthly return
8th Apr 20207:00 amRNSTrading Update and Covid-19 Statement
30th Mar 20204:36 pmRNSPrice Monitoring Extension
30th Mar 202012:08 pmRNSSecond Price Monitoring Extn
30th Mar 202012:02 pmRNSPrice Monitoring Extension
26th Mar 202012:07 pmRNSSecond Price Monitoring Extn
26th Mar 202012:02 pmRNSPrice Monitoring Extension
26th Mar 20207:00 amRNSAnnual General Meeting 2020 – Change of Venue
23rd Mar 20204:43 pmRNSSecond Price Monitoring Extn
23rd Mar 20204:38 pmRNSPrice Monitoring Extension
20th Mar 20204:43 pmRNSSecond Price Monitoring Extn
20th Mar 20204:37 pmRNSPrice Monitoring Extension
19th Mar 20204:43 pmRNSSecond Price Monitoring Extn
19th Mar 20204:39 pmRNSPrice Monitoring Extension
18th Mar 202012:08 pmRNSSecond Price Monitoring Extn
18th Mar 202012:03 pmRNSPrice Monitoring Extension
17th Mar 20204:41 pmRNSSecond Price Monitoring Extn
17th Mar 20204:38 pmRNSPrice Monitoring Extension
13th Mar 20204:42 pmRNSSecond Price Monitoring Extn
13th Mar 20204:36 pmRNSPrice Monitoring Extension
6th Mar 202010:20 amRNSHolding(s) in Company
18th Feb 202012:07 pmRNSSecond Price Monitoring Extn
18th Feb 202012:02 pmRNSPrice Monitoring Extension
18th Feb 20207:00 amRNSDirector/PDMR Shareholding
11th Feb 20203:15 pmRNSPDMR Shareholding Grant of Options
3rd Feb 20207:00 amRNSPreliminary Results and Board Changes
18th Dec 20195:39 pmRNSHolding(s) in Company
5th Dec 20197:00 amRNSPre-close trading update
2nd Dec 201911:20 amRNSHolding(s) in Company
2nd Dec 201911:20 amRNSHolding(s) in Company
13th Nov 20192:51 pmRNSHolding(s) in Company
31st Oct 20197:00 amRNSTotal Voting Rights
8th Oct 201910:00 amRNSBlock listing update
20th Sep 201911:38 amRNSDirector/PDMR Shareholding
18th Sep 20197:00 amRNSNine months trading update
5th Sep 20197:00 amRNSAcquisition of Dahlman Industrial Group B.V.
28th Aug 201912:07 pmRNSSecond Price Monitoring Extn
28th Aug 201912:02 pmRNSPrice Monitoring Extension
23rd Aug 201912:07 pmRNSSecond Price Monitoring Extn
23rd Aug 201912:02 pmRNSPrice Monitoring Extension
6th Aug 201912:07 pmRNSSecond Price Monitoring Extn
6th Aug 201912:02 pmRNSPrice Monitoring Extension
28th Jun 201911:30 amRNSDirector/PDMR Shareholding
27th Jun 20194:35 pmRNSPrice Monitoring Extension
24th Jun 20197:00 amRNSHalf Year Results 2019
18th Jun 20197:00 amRNSBoard changes
6th Jun 20197:00 amRNSTrading Update
15th Apr 201912:30 pmRNSHolding(s) in Company
11th Apr 20193:13 pmRNSAGM resolutions

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.